Evotec
Irving Donadon, PhD, MBA, possesses extensive experience in business development and scientific project management within the biotechnology sector. Currently serving as Senior Manager for Global Business Development in Cell Therapy at Evotec, Irving has previously held key roles including Commercial & Business Development Manager at Holostem Terapie Avanzate S.r.l., Business Development Consultant in a self-employed capacity, Scientific Program Manager at ICGEB, and Scientific Project Manager at Università degli Studi di Ferrara. This diverse background showcases a strong combination of scientific expertise and commercial acumen.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.